3D screen-printing technology offers the pharmaceutical industry wide-ranging opportunities for series production of innovative Drug Delivery Systems for the controlled systemic release of actives.


In the 3D screen-printing process all the process positions across the product creation chain are identical. No technology, process or parameter changes are made during product development, the production of prototypes and final series production.